Brief: Inventiva Announces Positive Recommendation Of The Third DMC Of The Phase III Clinical Trial With Lanifibranor In Patients With Nash

Inventiva SA

04/12/2023 21:08

Dec 4 (Reuters) - Inventiva Sa  IVAA.PA :
    * INVENTIVA ANNOUNCES THE POSITIVE RECOMMENDATION OF THE
THIRD DMC
OF THE PHASE III CLINICAL TRIAL WITH LANIFIBRANOR IN PATIENTS
WITH NASH
    * DMC RECOMMENDED TO CONTINUE CLINICAL TRIAL WITHOUT
MODIFICATION
OF PROTOCOL, BASED ON PRE-PLANNED REVIEW OF SAFETY DATA
    * DMC REVIEW REMAINS CONSISTENT, CONFIRMING GOOD SAFETY
PROFILE OF
LANIFIBRANOR

Source text for Eikon:  ID:nGNE35p8C4 
Further company coverage:  IVAA.PA 

 ((Reuters.Briefs@thomsonreuters.com;))